Biochemistry of Cardiac Muscle
Biochemistry of Cardiac Muscle
Biochemistry of Cardiac Muscle
of
Cardiac
Muscle
Arta
Farmawa7
Structure and
function
Motor
end-plates
None
None
Yes
Fibers
Branched
Mitochondria
Few
Many
Multiple
Sarcomeres
None
Electr. coupling
No
Sarcoplasmic
reticulum
Little developed
Moderately developed
Highly developed
Ca2+ switch
Troponin
Troponin
Pacemaker
Calmodulin/caldesmon
Some spontaneous rhythmic activity
(1s1 1h1)
Response to stimulus
All or none
Graded
Tetanizable
Yes
No
Yes
Work range
Length-force curve
is variable
In rising
length-force curve
+ 20
Response
to stimulus
Spike
mV 0
Spontaneous
fluctuation
20
Potential
Muscle
tension
60
60
100
0
200
400
600
ms
Absolutely
refractory
+ 20
mV 0
20
40
(see 2.15E)
Relatively
refractory
At peak of
length-force curve (see 2.15E)
Absolutely
refractory
+ 50
mV 0
50
100
100
200
300 400
ms
10
59
20
ms
30
LA
RA
LV
RV
FIGURE 1
Cardiac Muscle
178
T tubule
Mitochondrion
Sarcoplasmic
reticulum
Mitochondrion
Cisterna
Z line
I band
A band
Sarcotubular
network
FIGURE 3
Ultrastructure of a contractile cell. A contractile cell in the heart is very similar to skeletal muscle in
its basic cellular organization. (Modified from Katz AM. Physiology of the heart. New York: Raven Press, 1992.)
Conduc7le cells
Mechanical
energy
B. Regeneration of ATP
1 Cleavage of creatine phosphate
Reserve:
ca. 25 mol
per g muscle
ADP
CrP
Creatine
kinase
Glycogen
Reserve:
ca. 100 mol/g muscle
Blood
glucose
Liver
1
ATP
Glucose-6-P
1
ATP
anaerobic
1. Dephosphoryla7on
of
crea7ne
phosphat
2. Anaerobic
glycolysis
3. Aerobic
oxida7on
of
glucose
and
facy
acids
2 Anaerobic glycolysis
Net gain:
2 mol ATP/mol glucose
(3 mol ATP/mol glucose-6-P)
Long-term high
performance
4
ATP
Increase in lactic acid
2pyruvic acid
2pyruvate +2H
Drop in pH
2lactic acids
2H++2 lactate
Broken down
in liver
and heart
3 Oxidation of glucose
2
Acetyl-CoA
6O2
aerobic
Short-term
peak performance
ATP
Cr
Plate 2.17
Heat
H2O
6CO2
Krebs
cycle
Respiratory
chain
34
ATP
Endurance sport
73
The
heart
primarily
uses
facy
acids
(6080%),
lactate,
and
glucose
(2040%)
as
its
energy
sources
Ninety-eight
percent
of
cardiac
ATP
is
generated
by
oxida7ve
means;
2%
is
derived
from
glycolysis.
The
lactate
used
by
the
heart
is
taken
up
by
a
monocarboxylate
transporter
in
the
cell
membrane
that
is
also
used
for
the
trans-
port
of
ketone
bodies
Ketone
bodies
are
not
a
preferred
fuel
for
the
heart,
because
the
heart
prefers
to
use
facy
acids
Lactate
is
generated
by
red
blood
cells
and
working
skeletal
muscle.
When
the
lactate
is
used
by
the
heart,
it
is
oxidized
to
carbon
dioxide
and
water,
following
the
pathway
lactate
to
pyruvate,
pyruvate
to
acetyl-coA,
acetyl
CoA
oxida7on
in
the
TCA
cycle,
and
ATP
synthesis
through
oxida7ve
phosphoryla7on.
An
alterna7ve
fate
for
lactate
is
its
u7liza7on
in
the
reac7ons
of
the
Cori
cycle
in
the
liver
+i
Muscle Cell
Muscle
Gycogen
Muscle
Protein
Pyruvate
Glucogenic
Amino Acids
Blood
iVLii>
>V`VVi
Lactate
Alanine
Glucose
Pyruvate
Lactate
Glycogen
Liver
Figure 5.16 /i
VViiiii}Viv>V>iii>i`
v>ViVi/}Vi}iVVi>>V>L`>iiii
}V}iiViiViviv`> /
>}>>i
VV
FIGURE 8
Cardiac
Muscle
Contrac7on
Mechanism
Autonomic
control
sympathe7c
ac7va7on,
involving
catecholamine
release,
has
both
posi7ve
inotropic
and
chronotropic
eects
via
-adrenoceptors.
These
ac7ons
are
antagonized
by
parasympathe7c
release
of
acetylcholine
The
inotropic
eect
of
-s7mula7on
results
from
an
increase
in
the
intracellular
calcium
transient
caused
by
increases
in
ICa
and
sarcoplasmic
re7culum
calcium
release
Autocrine/paracrine
regula7on
cardiac
myocytes
are
in
ini7mate
contact
with
the
endothelial
cells
of
the
coronary
microvasculature,
which
are
ideally
posi7oned
to
sense
and
transduce
local
signals
(e.g.
mechanical
forces,
hypoxia,
hormones)
in
the
perfusing
blood
Coordinated
release
of
factors
such
as
nitric
oxide,
endothelin-1
and
angiotensin
II
by
these
endothelial
cells
allows
local
regula7on
of
contrac7le
func7on.
Some
of
these
factors
are
also
generated
by
cardiac
myocytes
themselves,
par7cularly
in
pathological
senngs
in pathological settings.
!+)!'/!
+0$ '$!&
$!,%
,))&+
)'($*%!
)+!,$,%
)$*
*+!%,$+!'&
)+)+
+!-+!'&
+)&*!&+
+!-
!&'+)'(!+
&!'+&*!&
&'+ $!&
&+
0'!$%&++!-+!'&
'*!+!-
!&'+)'(!+
$/+!'&
)'($*%!
)+!,$,%
,(+#
*+!%,$+!'&
*+!%,$+!'&
!+)!'/!
&!'+&*!&
&'+ $!&
&+
)'$%%$
/+),*!'&
)*
0+'($*%!
'&&+)+!'&
0'!$%&+
!**'!+!'&
2$-$'+!-+!'&&'&+)+!$*+)&+ !&'+)'(!+*+'(
2)+')$/+!'&$,*!+)'(!+*'++'%
$,))'.*!&!+&!&)*&)))'.*)*!&+ '%('&&+*'
/!++!'&1'&+)+!'&',($!&+*'&!+)!'/!&+0$ '$!&'&+ $!,%,))&+)
*!&!!&+'&$0'$$'.!&()!'))&)!*+!%,$+!'&
'*!+!-
$,*!+)'(!+
+!-
$,*!+)'(!+
Nitric
oxide
has
direct
ac7ons
on
cardiac
myocytes,
independent
of
its
vasodilator
eects.
These
include:
accelera7on
of
myocyte
relaxa7on
and
reduc7on
in
diastolic
tone,
resul7ng
from
a
reduc7on
in
myolament
calcium
responsiveness
small
posi7ve
inotropic
and
chronotropic
eects
damping
down
of
responses
to
-adrenergic
s7mula7on
Endothelin-1
a
potent
vasoconstrictor
and
posi7ve
inotrope
that
acts
by
increasing
both
the
calcium
transient
and
myolament
calcium
responsiveness.
Endothelin-1
may
s7mulate
release
of
angiotensin
II,
which
has
similar
ac7ons
and
may
therefore
amplify
the
eects
of
endothelin-1
Apartate
amino
transferase
Is
a
less
sensi7ve
index
of
myocardial
damage
Lactate dehydrogenase
Troponin
Homocysteine